KAPA Financials

Kairos Pharma, Ltd. - Financial statements & key metrics

Stock Price

$1.60

Market Cap

$18.77M

EPS

$-0.31

Balance Sheet Highlights

Total Assets

$5.77M

Total Liabilities

$992,000

Shareholders Equity

-

Cash & Equivalents

$1.27M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-3.96M

CapEx

-

Free Cash Flow

-

Profitability Metrics

00

ROE

-92.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is KAPA revenue?

View KAPA's income statement for detailed revenue data.

Is KAPA profitable?

Check KAPA's income statement for profitability data.

What is KAPA market cap?

KAPA has a market capitalization of $18.77M, making it a small-cap stock.

Does KAPA have debt?

View KAPA's balance sheet for debt information.

What is KAPA cash flow?

Cash flow data is available in the full financial statements.

Explore Categories